Showing results (301-310 of 386) with videos related to
Sort By:
Pageof 39
The Journal of Allergy and Clinical Immunology. in Practice|July 1, 2020
Work Group Report: COVID-19: Unmasking TelemedicineNathan Hare, Priya Bansal, Sakina S Bajowala, et al.Human Gene Therapy|September 9, 2008
Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trialWilliam W Hauswirth, Tomas S Aleman, Shalesh Kaushal, et al.Cancer Letters|December 1, 2012
Development of an anti-angiogenic therapeutic model combining scAAV2-delivered siRNAs and noninvasive photoacoustic imaging of tumor vasculature developmentQing Ruan, Lei Xi, Sanford L Boye, et al.Oncotarget|October 6, 2017
The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cellsGabriele Stefanzl, Daniela Berger, Sabine Cerny-Reiterer, et al.Methods (San Diego, Calif.)|November 5, 2002
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectorsSergei Zolotukhin, Mark Potter, Irene Zolotukhin, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 30, 2021
Gene therapy reforms photoreceptor structure and restores vision in NPHP5-associated Leber congenital amaurosisGustavo D Aguirre, Artur V Cideciyan, Valérie L Dufour, et al.Plos Medicine|October 28, 2005
Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of Leber congenital amaurosisMatthew L Batten, Yoshikazu Imanishi, Daniel C Tu, et al.Investigative Ophthalmology & Visual Science|July 1, 2008
AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEbeta mutationJi-Jing Pang, Sanford L Boye, Ashok Kumar, et al.Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvementArtur V Cideciyan, Samuel G Jacobson, William A Beltran, et al.Human Gene Therapy. Clinical Development|October 13, 2017
Safety and Efficacy of AAV5 Vectors Expressing Human or Canine CNGB3 in CNGB3-Mutant DogsGuo-Jie Ye, András M Komáromy, Caroline Zeiss, et al.Pageof 39